The WACKER Group maintained its growth course in 2008. In spite of much higher capital expenditures, WACKER still has a strong equity base. Additionally, cash and cash equivalents exceed current and noncurrent financial liabilities. WACKER is thus free of debt.
download table |
|
|
|
Supplemental information. German Takeover Directive Implementation Act |
||
|
|
|
Regulation |
Topic |
Details and references |
|
|
|
§ 315 (4) 1 |
Composition of subscribed capital |
Wacker Chemie AG’s subscribed capital totals |
§ 315 (4) 2 |
Restrictions on voting rights or on the transfer of shares |
There are no restrictions on voting rights or the transfer of shares. |
§ 315 (4) 3 |
Direct or indirect capital stakes |
Dr. Alexander Wacker Familiengesellschaft mbH, based in Munich, and Blue Elephant Holding GmbH, based in Pöcking, each hold over 10% of the subscribed capital. |
§ 315 (4) 4 |
Owners of shares entailing special rights |
Shareholders have not been given any special rights that bestow control powers. Insofar as employees hold shares in Wacker Chemie AG’s capital, they exercise their resultant control rights directly. |
§ 315 (4) 6 |
Legal stipulations and articles of incorporation principles regarding the appointment and dismissal of executive board members and amendments to said articles |
Provisions to appoint and dismiss Wacker Chemie AG’s Executive Board members are based on Sections 84 et seq., of the German Stock Corporation Act (AktG). Wacker Chemie AG’s Articles of Incorporation do not contain any further provisions in this respect. Pursuant to Section 4 of the Articles of Incorporation, the number of Executive Board members is fixed by the Supervisory Board, which also appoints an Executive Board member as President & CEO. Amendments to the Articles of Incorporation are covered by Sections 133 and 179, AktG. In accordance with Section 179, Subsection 1, item 2, AktG, the Supervisory Board has been empowered to amend the Articles of Incorporation if only the wording thereof is affected. |
§ 315 (4) 7 |
Authority of the executive board |
In accordance with a resolution passed at the March 15, 2006 Annual Shareholder Meeting, Wacker Chemie AG’s Executive Board was authorized – in compliance with the legal provisions set out in Section 71, Subsection 1, No. 8 of the German Stock Corporation Act (AktG) – to acquire treasury shares totaling a maximum of 10% of capital stock. No capital has been authorized for the issue of new shares. |
§ 315 (4) 8 |
Major agreements associated with control changes due to takeover bid |
Various agreements with joint-venture partners include “change of control” clauses. These clauses deal with what might happen if one of the joint-venture partners were taken over. These arrangements comply with the usual standards for such joint-venture agreements. |
§ 315 (4) 9 |
Severance agreements with the executive board or employees in the event of a takeover bid |
There are no severance agreements etc. with employees or with Executive Board members in the event of a takeover bid (please refer to the Compensation Report). |
In sum, there are no special arrangements for share-related voting rights or any resultant control opportunities, whether due to special share categories or restrictions on voting rights or transfers. Provisions to appoint or dismiss Executive Board members do not go above and beyond legal requirements. Should there be a takeover bid, no major WACKER divisions and activities can be given up as a result of existing “change of control” clauses.